References
-
1.
Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2). ee19169.
-
2.
Pourmand GR, Allameh F, Mohammad K, Dehghani S, Pourmand B, Mehrsai AR, et al. Prostate cancer predicting factors: a preliminary report from Tehran. Urol J. 2012;9(4):667-72. [PubMed ID: 23235971].
-
3.
Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci. 2006;11:1388-413. [PubMed ID: 16368524].
-
4.
Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003;42(7):1805-12. [PubMed ID: 12590567]. https://doi.org/10.1021/bi027147i.
-
5.
Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, et al. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep. 2012;39(3):2347-53. [PubMed ID: 21656378]. https://doi.org/10.1007/s11033-011-0985-x.
-
6.
Kheirandish P, Chinegwundoh F. Ethnic differences in prostate cancer. Br J Cancer. 2011;105(4):481-5. [PubMed ID: 21829203]. https://doi.org/10.1038/bjc.2011.273.
-
7.
Mi Y, Yu Q, Min Z, Xu B, Zhang L, Zhang W, et al. Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysis. J Biomed Res. 2010;24(5):365-73. [PubMed ID: 23554651]. https://doi.org/10.1016/S1674-8301(10)60049-8.
-
8.
Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, et al. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Cancer Res. 2003;63(20):6795-801. [PubMed ID: 14583476].